Story maps
故事地圖



(added on 2014/01/16)

Linkages of new resistant bacteria 耐藥細菌的連繫網絡

©2014 SpatioEpi.com
Data source: CHP and published scientific literature
Map created by CUHK SpatioEpi Group
地圖資料源自衛生署衛生防護中心及已刊登的科學文獻。

Enlarge   Back


New Delhi metallo-beta-lactamase (NDM) was first detected in a bacterial isolate in 2008 from a Swedish patient who had been admitted to a hospital in India. By the end of 2013, NDM have been identified in over 50 countries.

In Hong Kong, there were a total of 36 reported cases of NDM bacteria. The number of cases increased significantly in the past two years. The map shows the epidemiological links of the reported cases in Hong Kong, most of which had travel or healthcare history elsewhere in Asia. Seven patients had travelled to India whereas the majority (21/36; 58.3%) were associated with living or being hospitalized in Mainland China. Apparently, acquisition of bacteria with NDM strains was no longer limited to the Indian subcontinent.

Data for the map were obtained from Centre for Health Protection, Department of Health, Hong Kong and published scientific literature.

新德里金屬-β-內酰胺酶(簡稱NDM)是一種新的耐藥細菌特質,首次從一名瑞典病人抽取的細菌樣本裡被發現,該名病人曾於2008年留醫印度。至2013年底,全球已有超過50個國家呈報含NDM泛耐藥細菌的個案。

香港至今亦有36宗含NDM泛耐藥腸桿菌科細菌個案,而近兩年的個案數字亦明顯有所上升。地圖顯示這些香港個案與各地的流行病學聯係,當中大部分個案的病人均有外遊亞洲各國或使用其醫療服務的記錄。譬如,其中七位病人曾到訪印度,而其他21宗個案或與長居內地或曾於內地留醫相關。明顯地,感染含NDM泛耐藥細菌已不再限於印度次大陸。